LGALS3BP and gestational trophoblastic neoplasm: Further research is needed to determine the resistance mechanisms of LGALS3BP in GTN to draw a clearer conclusion, and to explore the clinical potential of targeting LGALS3BP to sensitize GTN cells to chemotherapeutic drugs.